ME
Medios AG
MEDOF · OTC
$50.00 +0.00% (+$0.00)
Market Cap 1.11B €
P/E Ratio 98.78x
Div. Yield -
ROE 2.16%
Bulios Fair Price
$35.89
28.2% downside
Current Price
$50
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MEDOF is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
40 /100
Fair P/FCF 40.34x
P/S 0.51x
P/B 2.11x
Growth
68 /100
Growing Rev. growth 11.53%
FCF growth 11.42%
Book val. growth 8.98%
Profitability
9 /100
Weak Net margin 0.52%
Op. margin 1.88%
FCF margin 1.27%
Quality
23 /100
Poor ROE 2.16%
ROA 1.22%
Asset turnover 2.35x
Debt
75 /100
Low Current ratio 1.84x
Int. coverage 2.75x
Net debt/EBITDA 1.44x
Stability
57 /100
Moderate Rev. volatility 6.62%
EPS volatility 75.39%
Profitable years 4
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MEDOF
Online
Sector
Healthcare
Industry
Medical - Distribution
CEO
Thomas Meier
Employees
993
Headquarters
Berlin
Upcoming events
10 NOV
Earnings
Upcoming earnings report